|
|
Obesity Pharmacology in Clinical Practice: Current Strategies and New Horizons
Recorded for 2025 Fall Conference
|
|
Facebook
LinkedIn
E-Mail
|
(1070)
|
Activity Duration| Content Expires: | February 28, 2027 (11:55 p.m. CT)
CE for this activity will not be available after this date. |
This CE activity was recorded for the 2025 AANP Fall Conference.  | This activity includes closed captioning. |
| Delivery Note: The content for this activity was previously presented during the virtual 2025 AANP Fall Conference. If you already completed the content of this activity while attending the virtual conference, you should not complete this content a second time. Learners should only complete ONE delivery-method to earn credit. Completing multiple delivery options for the same activity is considered duplicate credit for the same content and will not be accepted by regulatory bodies. |
Overview
As obesity is increasingly recognized as a chronic, progressive, and neurobehavioral disease, pharmacologic treatment has become a cornerstone of effective, long-term management. This presentation will provide a comprehensive review of current and emerging anti-obesity medications, focusing on mechanisms of action, indications, dosing strategies, contraindications, and adverse effect profiles. Participants will explore drug classes including sympathomimetic agents, GLP-1 receptor agonists, combination therapies, and newer agents such as dual and triple incretin receptor agonists. Clinical case studies will guide the application of pharmacologic principles in real-world scenarios, emphasizing individualized therapy based on comorbidities and patient preferences. The session will also address deprescribing obesogenic medications and optimizing polypharmacy in complex patients. Additionally, the presentation will highlight systemic challenges, including limited pharmacotherapy utilization and weight-related bias in prescribing patterns. Nurse practitioners will gain enhanced competency in selecting, initiating, titrating, and monitoring obesity medications in alignment with current clinical guidelines and evidence-based practice.
Objectives
- Describe the pharmacologic mechanisms of action, indications, and contraindications for current and emerging anti-obesity medications.
- Compare drug classes used in obesity treatment, including efficacy, safety profiles, and side effect management.
- Develop individualized obesity management plans incorporating pharmacotherapy, lifestyle interventions, and comorbidity considerations.
- Evaluate clinical case scenarios to select and adjust appropriate pharmacologic therapies.
- Identify prescribing barriers including weight bias and systemic care gaps.
Speaker
Shannon Idzik, DNP, ANP-BC, FAANP, FAAN
Disclosure
This program was planned in accordance with AANP CE Standards and Policies.
The speaker has the following disclosures:- I have nothing to disclose.
DisclaimerIndividuals who have contributed to the CE Center (content originally from the 2025 AANP Fall Conference) were carefully selected for their knowledge and experience in the subject area under review. This presentation is informational only and may contain opinions of the authors from their personal experience that do not necessarily express the opinions of the American Association of Nurse Practitioners (AANP). The activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Clinical practice is a constantly changing process and new information becomes available every day. Neither AANP nor the contributing individuals can warrant that the material will continue to be accurate, nor do they warrant that the material is completely free of errors upon publication. Attendees and participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.
CE Credit Instructions
- Read this activity description, including objectives and disclosures.
- Complete all educational content:
- OnDemand Presentations: Click the Play button to watch the activity video lecture. To get full credit for the learning activity portion, you must watch all of the video content.
- Click on the Additional Resources button to review all additional materials provided (handouts and any other downloadable resources).
- After completing all educational content, go to the Next Steps button:
- Submit the activity evaluation to receive full AANP CE/Rx credit.
- Click on the Get Certificate button. At the top of the certificate screen, use the provided dropdown menu and select AANP Certificate of Completion.
- A copy of your certificate of completion will display on the screen for you to print or save. A copy of the certificate will also be emailed to you.
- A copy of the certificate will be automatically added to your AANP CE Tracker.
Additional Information
For questions or more information concerning this online CE activity, please visit the AANP Help Center to find answers to frequently asked questions and request assistance.
0.88 Contact Hour(s) of CE,
All of which may be applied towards Pharmacology
|
|
Additional CE activities of interest
(OnDemand)
Acute Kidney Injury and Chronic Kidney Disease: Guideline Updates
(OnDemand)
Migraine, Diagnosis and Treatment Tried, True and New
(OnDemand)
Managing Insomnia
(OnDemand)
Autoimmune Diseases in Dermatology: Diagnosis, Management, and Clinical Pearls
(OnDemand)
Beyond Medications: Non-Pharmacologic Strategies for Acute & Chronic Disease Management
(OnDemand)
MODULE 6: Opioid Prescribing Update
(OnDemand)
Infestations, Bites & Stings
(OnDemand)
The Aging Face and Non-Surgical Strategies to Prevent the Effects of Aging
(OnDemand)
Understanding Cardiomyopathies
(OnDemand)
MODULE 3: Non-Opioid Pharmacology Treatment of Pain
(OnDemand)
MODULE 1: Pathophysiology of Pain and Neurobiology of Addiction Overview
(OnDemand)
MODULE 5: Substance Use Disorders - Opioids
|
|
Adding Registration, Please wait...
